Utama › Kanser Paru-paru Bukan Sel Kecil › Indiana › Hammond
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Hammond, IN
11 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Hammond (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Mengambil pesertaFasa 3
- The Community Hospital, Munster · 1 mi jauh
- Women's Diagnostic Center - Munster, Munster · 1 mi jauh
- Northwest Oncology LLC, Dyer · 6 mi jauh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- The Community Hospital, Munster · 1 mi jauh
- Women's Diagnostic Center - Munster, Munster · 1 mi jauh
- Northwest Oncology LLC, Dyer · 6 mi jauh
- dan 2 lagi
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Mengambil pesertaFasa 3
- Northwest Cancer Centers, P.C., Dyer · 6 mi jauh
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- Franciscan Health, Munster · 1 mi jauh
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Mengambil pesertaFasa 3
- Northwest Cancer Centers, P.C., Dyer · 6 mi jauh
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Ingalls Family Care Center, Calumet City · 3 mi jauh
- UChicago Medicine Ingalls Memorial, Harvey · 8 mi jauh
- UChicago Medicine at Ingalls - Flossmoor, Flossmoor · 10 mi jauh
- dan 1 lagi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Mengambil pesertaFasa 1/2
- Northwest Cancer Centers, Dyer · 6 mi jauh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Hammond
- Kanser Paru-paru10 kajian
- Kanser Payudara9 kajian
- Kegagalan Jantung8 kajian
- Kanser Ovari5 kajian
- Kanser Kolorektal5 kajian
- Tekanan Darah Tinggi4 kajian
- Kanser Pankreas4 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher4 kajian
- Degenerasi Makula4 kajian
- Kanser Ginjal (Karsinoma Sel Renal)4 kajian
- Kanser Metastatik3 kajian
- Kanser (semua jenis)3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.